Sabine Linn

Full Professor

Strategic program(s):

Contact

slinn2@umcutrecht.nl

Pure profile

Research groups

Translational breast cancer research group

Research aim

We aim to optimize early diagnosis and treatment of breast cancer, especially rare breast cancers like pregnancy associated, male & lobular breast cancer. We refine tissue diagnostics with molecular techniques/AI, and apply nipple fluid/blood tests.

Go to group

Recent publications

All publications

Invasive lobular breast cancer in young patients without adjuvant systemic treatment R A B Voorthuis, M Opdam, N D Ter Hoeve, M da Silva, M Christgen, G Dackus, P V Diest, P W B Derksen, F S Hilbers, S C Linn
Breast Cancer Research and Treatment, 2026, vol. 218

Tailoring radiotherapy in cT1–2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03) Annefleur J.W. Mauritz, Linda de Munck, Janine M. Simons, Janneke Verloop, Thijs van Dalen, Paula H.M. Elkhuizen, Astrid Scholten, Ruud M.A. Houben, A. Elise van Leeuwen-Stok, Sabine C. Linn, Ruud M. Pijnappel, Philip M.P. Poortmans, Luc J.A. Strobbe, Jelle Wesseling, Adri C. Voogd, Liesbeth J. Boersma
The Lancet Oncology, 2026, vol. 27, p.808-816

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO) Rianne L Seefat, Sonja B Vliek, Vincent M T de Jong, Sara Balduzzi, Ingrid A Mandjes, Valesca P Retèl, Inge Eekhout, Marjolein Delfos, Margaret Schot, Marjo J Holtkamp, Mandy M van Rosmalen, Brenda Leeneman, Hedwig Blommestein, Alwin D R Huitema, Efraim H Rosenberg, Petra M Nederlof, Terry W S Chan, Anna van Rhenen, Marielle J Wondergem, Nicolaas P M Schaap, Tjeerd J F Snijders, Marjolein W M Van der Poel, Wouter J Plattel, Erik van Werkhoven, Harm van Tinteren, Marjolein L Smidt, Jelle Wesseling, Jos Jonkers, Sven Rottenberg, Marie-Jeanne T F D Vrancken Peeters, Carlijn Voermans, John H Maduro, Judith R Kroep, Carolien P Schroder, Evelien J M Kuip, Anthony Gonçalves, Janine Nuver, A N Machteld Wymenga, Rhodé M Bijlsma, Elsken van der Wall, Inge R H M Konings, Vivianne C G Tjan-Heijnen, Mojca Jongen-Lavrencic, Agnes Jager, Sabine C Linn
The Lancet Oncology, 2026, vol. 27, p.795-807

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival Y Wang, D Drubay, S F Jonas, J Dixon-Douglas, B Acs, S Adams, F André, S Badve, G Bataillon, J M Carter, S Chia, V Cockenpot, M A Colleoni, C Criscitiello, G Curigliano, G M H E Dackus, S Demaria, C Denkert, C H M van Deurzen, M V Dieci, D Giardiello, M P Goetz, R J Gray, M Hauptmann, N D Ter Hoeve, K Jóźwiak, E A Koop, V M T de Jong, H Joensuu, G Jules-Clément, R Kammler, P L Kellokumpu-Lehtinen, S B Kim, M Kok, M Lacroix-Triki, M Lambertini, H J Lee, J Lemonnier, R A Leon-Ferre, S Leung, B Linderholm, S Loibl, J W M Martens, T O Nielsen, M Opdam, P Pharoah, F Penault-Llorca, P J van Diest, S C Linn, M K Schmidt,
Annals of Oncology, 2026, vol. 37, p.1093-1105

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer Aldo Caltavituro, Roberto Buonaiuto, Alessandra Longobardi, Paola Trasacco, Claudia Martinelli, Giuseppe Di Grazia, Roberto Pacelli, Grazia Arpino, Carmine De Angelis, Roberta Caputo, Michelino De Laurentiis, Elena Laakmann, Leonor Vasconcelos de Matos, Mário Fontes-Sousa, Mette van Ramshorst, Volkmar Mueller, Elisa Agostinetto, Sabine Linn, Michelangelo De Angelis, Francesco Schettini, Mario Giuliano
Cancer treatment reviews, 2026, vol. 147

Coverage with evidence development programs Joost G.E. Verbeek, Rianne L. Seefat, Erica A. Wilthagen, Agnes Jager, Sabine C. Linn, Valesca P. Retèl, Wim H. van Harten
Health Policy, 2026, vol. 171